As a test of whether RASSF10 expression was potentially affected by promoter region hypermethylation, these colorectal cancer cell lines were treated by 5-aza-2′-deoxycytidine (5-aza), a DNA methylation transferase inhibitor. This evidence concerns the gene RASSF10 and colorectal cancer.